Home › Funds › Vestal Point Capital, LP › TARS

Vestal Point Capital, LP position in TARS

TARSUS PHARMACEUTICALS INC · Health Care

Vestal Point Capital, LP reported holding 1,050,000 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$66.1M, representing 1.54% of its reported portfolio and ranking #23 among its reported holdings. Vestal Point Capital, LP has disclosed TARS holdings in 3 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.05M sh
Reported value held$66.09M
Portfolio Weight1.54%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's TARS position evolved

Vestal Point Capital, LP first disclosed a stake in TARS in Q3 2024 at 230,000 shares (US$7.6M). The position peaked in Q2 2026 at 1,050,000 shares, worth US$66.1M. Across 3 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,050,000 shares valued at US$66.1M — an increase of 850,000 shares quarter over quarter.. Notable position changes include a 425% increase in Q2 2026 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 230.00K $7.56M New
Q1 2026 200.00K $14.03M New
Q2 2026 1.05M $66.09M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARS and 13F data

TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$230.8M), RTW INVESTMENTS, LP (US$211.3M), Paradigm Biocapital Advisors LP (US$174.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARS

All TARS fund holders →

FAQ

How long has Vestal Point Capital, LP held TARS?

Vestal Point Capital, LP has disclosed TARS holdings in 3 of the last 8 reported quarters, going back to Q3 2024.

What is Vestal Point Capital, LP's current position in TARS?

As of Q2 2026, Vestal Point Capital, LP holds 1.05M shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $66.09M, representing 1.54% of its reported portfolio and ranking #23.

Has Vestal Point Capital, LP been buying or selling TARS?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in TARS. The position peaked in Q2 2026 at 1.05M shares.

Which other funds hold TARS?

Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.